U.S. Allows Emergency Use Of Eli Lilly's COVID-19 Antibody Therapy

The U.S. Food and Drug Administration on Monday authorized emergency use of Eli Lilly and Co's experimental COVID-19 antibody treatment, which President Donald Trump has praised and vowed to make available free of cost for all Americans.

​

The FDA said its emergency use authorization was based on clinical trials showing that the treatment, bamlanivimab, reduced the need for hospitalization or emergency room visits in COVID-19 patients at high risk of disease progression. It can be used for treating mild-to-moderate COVID-19 in adults and pediatric patients over the age of 12, the FDA said.

—Reuters Staff

Source